Type 2 & other diabetes

Assessment of left atrioventricular coupling and left atrial function impairment in diabetes with and without hypertension using cardiac magnetic resonance (CMR) feature tracking

Cardiovasc DiabetolPublished Cross-sectional study

Authors' conclusion

In DM patients, LV GLS showed a significant association with LA phasic strain. Hypertension was found to exacerbate the decline in LA booster strain and increase LACI in DM patients, indicating potential atrioventricular coupling index alterations.

Study context

Population
Patients with clinically diagnosed diabetes mellitus (DM) who underwent CMR at one hospital, December 2015 to June 2022
Participants
176 patients
Exposure
DM with hypertension vs DM without hypertension
  • DM + HPn = 103
  • DM-HPn = 73reference
Outcome
LACI and LA function (reservoir, conduit and booster-pump strain and LA ejection fraction (LAEF))
Methodological detailsconsecutive recruitment, CMR feature tracking, single hospital
  • Consecutive recruitment
  • CMR feature tracking
  • Single hospital

Main finding

As reported in the abstract

LA function and LACI, adjusted for age, sex, BSA and current smoking
  • DM + HP vs DM-HP: P = 0.013
  • DM + HP vs DM-HP: P = 0.017
  • DM + HP vs DM-HP: P = 0.807
  • DM + HP vs DM-HP: P = 0.006
  • DM + HP vs DM-HP: P = 0.037
  • DM + HP vs DM-HP: P = 0.019
  • DM + HP vs DM-HP: P = 0.049
  • Adjusted for age, sex, body surface area (BSA) and current smoking

Observational data: associations, not effects.

Further findings

Multivariate associations of LV GLS with left atrial (LA) strain and left atrioventricular coupling index (LACI) in DM

LV GLS and εs, β
−1.286, p < 0.001
LV GLS and εe, β
−0.919, p < 0.001
LV GLS and εa, β
−0.324, p = 0.036
LV GLS and LACI, β (not significant)
−0.003, p = 0.075

Hypertension as independent contributor in DM

Decreased εa, β
−2.508, p = 0.027
Increased LACI, β
0.05, p = 0.011

Original publication

Assessment of left atrioventricular coupling and left atrial function impairment in diabetes with and without hypertension using CMR feature tracking. Cardiovasc Diabetol. Published 30 October 2023. doi:10.1186/s12933-023-01997-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.